News

Hosted on MSN1m
Eli Lilly's Path to the Next Trillion Market Capitalization
Eli Lilly and Co. (NYSE: LLY) is a pharmaceutical giant that's made headlines for its GLP-1/GIP weight loss drug Tirzepatide, ...
STAT56m
Pharmalittle: We’re reading about FDA forcing out top gene therapy regulator, Gilead’s HIV challenges and more
And more pharma news updates from Pharmalittle.
sharewise34m
McDonald’s Is Down, But Long-Term Investors Can Still Take a Bite
McDonald’s Corp. (NYSE: MCD) stock has declined by about 8% over the past month, as analysts are not particularly impressed ...